rifaximin

In fact, a major paper was recently published in the Annals of Internal Medicine that showed using a non-absorbed antibiotic called rifaximin for 10 days resulted in a dramatic improvement in bloating and overall symptoms of IBS by clearing out the overgrowth of bacteria. (ii) This medication is now under FDA review for approval as a new treatment for irritable bowel syndrome.

5 Simple Steps to Cure IBS (VIDEO) 2010

In fact, a major paper was recently published in the Annals of Internal Medicine that showed using a non-absorbed antibiotic called rifaximin for 10 days resulted in a dramatic improvement in bloating and overall symptoms of IBS by clearing out the overgrowth of bacteria. (ii) This medication is now under FDA review for approval as a new treatment for irritable bowel syndrome.

Mark Hyman, MD: 5 Simple Steps to Cure IBS (VIDEO) 2010

Preliminary studies suggested that rifaximin, which is sold by Salix Pharmaceuticals Inc. under the brand name Xifaxin, could kill off the bacteria, easing symptoms.

The Seattle Times 2011

The industry-sponsored research shows that two weeks of treatment with an antibiotic called rifaximin quelled the symptoms of moderate IBS in 41 percent of the patients who took it.

NPR Topics: News 2011

Preliminary studies suggested that rifaximin, which is sold by

latimes.com - News 2011

Salix Pharmaceuticals, which markets rifaximin under the name Xifaxan in the U.S., is seeking to expand its use to IBS.

Antibiotic shown to relieve common bowel disorder 2011

Cedars-Sinai holds a patent on the use of rifaximin for irritable bowel syndrome.

Antibiotic shown to relieve common bowel disorder 2011

In two large studies, 41% of the patients who took the antibiotic rifaximin said their symptoms substantially improved, compared to 32% of those who got fake pills.

Antibiotic shown to relieve common bowel disorder 2011

Participants were assigned to take 550 milligrams of rifaximin or dummy pills for two weeks, three times a day.

Antibiotic shown to relieve common bowel disorder 2011

In the U.S., rifaximin is approved for traveler's diarrhea and for a complication of liver disease.

Antibiotic shown to relieve common bowel disorder 2011